MORE PAIN AHEAD FOR J&J

Johnson & Johnson, coming off one of its most challenging years ever, is bracing for what could be an even worse year. In 2019, the world’s largest maker of healthcare products, is scheduled to face almost three times as many trials over its once-beloved and best-known, but now highly controversial baby powder. NoPo says – asbestos or no asbestos, play it safe and just stop using it .. and maybe sell the stock, which is already down about 10% year-to-date.

Connect With Us